Home/lupin/Ramesh Swaminathan
RS

Ramesh Swaminathan

Executive Director, President – Finance & Planning, CFO

lupin

lupin Pipeline

DrugIndicationPhase
Sugammadex InjectionNeuromuscular blockade reversalApproved (Tentative)
Pitolisant TabletsNarcolepsyApproved (Tentative)
Semaglutide InjectionType 2 Diabetes, ObesityMarket
Novel GLP-1 Receptor AgonistMetabolic DisordersPre-clinical/Clinical
Biosimilars PortfolioOncology, ImmunologyVarious
Plasil®GastroenterologyMarket